Bar-ilan University

Sivan Elhanati

Haim Yosef Cohen

Yariv Kanfi

An aspect of an embodiment of the invention relates to providing treatment of disease, in particular age-related disease, through increasing or decreasing the activity of SIRT6 protein. This may be accomplished through upregulation and downregulation of expression of SIRT6 in mammals. It has been found by the inventors that mice over-expressing SIRT6 have a longer lifespan in comparison to control mice, indicating that increasing SIRT6 expression can lengthen lifespan of mammals. Agents which modulate SIRT6 expression through, for example binding to 3'UTR region of human mRNA encoding SIRT6 or by blocking binding of agents to 3&#x2032;UTR region of human mRNA encoding SIRT6, have been identified.

Growing community of inventors

Petach Tikva, Israel

Sivan Elhanati